Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Cough, cold and allergy (hay fever) continues to rebound following the declines during the COVID-19 pandemic and the slow recovery in its aftermath. Unit prices have been driven up by inflation resulting in double-digit current value growth in 2023,…
During the last couple of years, the flu season was virtually non-existent as a result of Croatians staying at home and, when venturing out in public, wearing face masks, maintaining social distance and frequently washing their hands. This…
Whilst the category continues to record growth in 2023, the particularly high growth level seen in the previous year could not be maintained. 2022 was a strong year for the category as consumers returned to their pre-pandemic lifestyles following the…
The majority of subcategories within cough, cold and allergy remedies recorded positive growth in retail volume terms in 2023. This was due, in a large part, to a return pre-pandemic lifestyles, which facilitated the spread of the influenza virus and…
Following the return to normality in the wake of the COVID-19 crisis, with no more lockdowns or movement restrictions, there has been an increase in the spread of cold and flu viruses, as well as a widespread rise in issues caused by hay fever and…
In 2022, cough, cold and allergy (hay fever) remedies was marked by increases in demand for products to soothe sore throat and cough complaints. This development was a result of extremely high morbidity throughout the year. In the first half of 2022,…
Analgesics is expected to register moderate constant value growth in 2023. Though there was widespread severe flu in early 2023, cough and cold remedies are not expected to benefit to a huge degree, as most of these patients were hospitalised or put…
Cough, cold and allergy (hay fever) remedies in Latvia is registering moderate growth in 2023 as the category begins to stabilise post-pandemic. Retail value sales rebounded strongly 2022 after two years of decline, with lifestyles shifting back to…
2023 marks the year when the cough and cold landscape is set to lose its uplift due to COVID-19, returning to a level closer to that seen pre-pandemic. Sales have continued to benefit from harsh seasonal colds and the flu season of 2022-2023.…
Cough, cold and allergy (hay fever) remedies is seeing slower growth in 2023 due to a shorter cold season caused by milder winter 2022/2023. The exception is antihistamines, which continues to grow at a solid rate due to high consumer demand amidst…